BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22214745)

  • 1. Anemia in heart failure.
    Kılıçgedik A; Dündar C; Tigen MK
    Anadolu Kardiyol Derg; 2012 Feb; 12(1):65-70. PubMed ID: 22214745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction between heart failure and other heart diseases, renal failure, and anemia.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Semin Nephrol; 2006 Jul; 26(4):296-306. PubMed ID: 16949468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia in chronic congestive heart failure: frequency, prognosis, and treatment.
    Crosato M; Steinborn W; Anker SD
    Heart Fail Monit; 2003; 4(1):2-6. PubMed ID: 12808478
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anemia and chronic heart failure implications and treatment options.
    Anand IS
    J Am Coll Cardiol; 2008 Aug; 52(7):501-11. PubMed ID: 18687241
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erythropoietin improves anemia exercise tolerance and renal function and reduces B-type natriuretic peptide and hospitalization in patients with heart failure and anemia.
    Palazzuoli A; Silverberg D; Iovine F; Capobianco S; Giannotti G; Calabrò A; Campagna SM; Nuti R
    Am Heart J; 2006 Dec; 152(6):1096.e9-15. PubMed ID: 17161060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Congestive heart failure-related anemia and a role for erythropoietin.
    Akram K; Pearlman BL
    Int J Cardiol; 2007 May; 117(3):296-305. PubMed ID: 16901559
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy insight: congestive heart failure, chronic kidney disease and anemia, the cardio-renal-anemia syndrome.
    Iaina A; Silverberg DS; Wexler D
    Nat Clin Pract Cardiovasc Med; 2005 Feb; 2(2):95-100. PubMed ID: 16265380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of anemia in the progression of congestive heart failure. Is there a place for erythropoietin and intravenous iron?
    Silverberg DS; Wexler D; Iaina A
    J Nephrol; 2004; 17(6):749-61. PubMed ID: 15593047
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The anemia of heart failure.
    Silverberg DS; Wexler D; Palazzuoli A; Iaina A; Schwartz D
    Acta Haematol; 2009; 122(2-3):109-19. PubMed ID: 19907148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anemia and outcomes in patients with heart failure: a study from the National Heart Care Project.
    Kosiborod M; Curtis JP; Wang Y; Smith GL; Masoudi FA; Foody JM; Havranek EP; Krumholz HM
    Arch Intern Med; 2005 Oct; 165(19):2237-44. PubMed ID: 16246989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of correction of anaemia in patients with congestive heart failure: a short review.
    Silverberg DS; Wexler D; Iaina A; Schwartz D
    Eur J Heart Fail; 2008 Sep; 10(9):819-23. PubMed ID: 18703380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition and treatment of anemia in the setting of heart failure due to systolic left ventricular dysfunction.
    Howlett JG
    Expert Rev Cardiovasc Ther; 2008 Feb; 6(2):199-208. PubMed ID: 18248274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients.
    van der Putten K; Jie KE; van den Broek D; Kraaijenhagen RJ; Laarakkers C; Swinkels DW; Braam B; Gaillard CA
    Eur J Heart Fail; 2010 Sep; 12(9):943-50. PubMed ID: 20601671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of erythropoietin in heart failure management.
    Caiola K; Cheng JW
    Ann Pharmacother; 2004 Dec; 38(12):2145-9. PubMed ID: 15494385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cardio-renal anemia syndrome.
    Iaina A; Silverberg DS; Wexler D; Iaina Nomy L
    Med Pregl; 2007; 60 Suppl 2():145-50. PubMed ID: 18928182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia and heart failure: statement of the problem.
    Lewis BS; Karkabi B; Jaffe R; Yuval R; Flugelman MY; Halon DA
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii3-6. PubMed ID: 16024830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The interaction between heart failure, renal failure and anemia - the cardio-renal anemia syndrome.
    Silverberg DS; Wexler D; Blum M; Wollman Y; Schwartz D; Sheps D; Keren G; Iaina A
    Blood Purif; 2004; 22(3):277-84. PubMed ID: 15166489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaemia and heart failure: aetiology and treatment.
    Klutstein MW; Tzivoni D
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii7-10. PubMed ID: 16024833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.